Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clostridium difficile infection in hospitals: risk factors and responses.

Literature DB >> 15238495

Clostridium difficile infection in hospitals: risk factors and responses.

Thomas J Louie¹, Jon Meddings.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2004 PMID： 15238495 PMCID： PMC437683 DOI： 10.1503/cmaj.1040966

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

16 in total

1. Autoradiographic demonstration of lansoprazole uptake sites in rat antrum and colon.

Authors: M Nakamura; M Oda; Y Akiba; J Inoue; T Ito; M Tsuchiya; H Ishii
Journal: J Clin Gastroenterol Date: 1995 Impact factor: 3.062

2. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

Authors: S Johnson; M H Samore; K A Farrow; G E Killgore; F C Tenover; D Lyras; J I Rood; P DeGirolami; A L Baltch; M E Rafferty; S M Pear; D N Gerding
Journal: N Engl J Med Date: 1999-11-25 Impact factor: 91.245

3. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

Authors: M Impallomeni; N P Galletly; S J Wort; J M Starr; T R Rogers
Journal: BMJ Date: 1995-11-18

4. Identification of a vanadate-sensitive potassium-dependent proton pump from rabbit colon.

Authors: J D Kaunitz; G Sachs
Journal: J Biol Chem Date: 1986-10-25 Impact factor: 5.157

5. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.

Authors: C B Kurtz; E P Cannon; A Brezzani; M Pitruzzello; C Dinardo; E Rinard; D W Acheson; R Fitzpatrick; P Kelly; K Shackett; A T Papoulis; P J Goddard; R H Barker; G P Palace; J D Klinger
Journal: Antimicrob Agents Chemother Date: 2001-08 Impact factor: 5.191

6. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

Authors: M Tvede; J Rask-Madsen
Journal: Lancet Date: 1989-05-27 Impact factor: 79.321

7. Regulation of colonic H-K-ATPase in large intestine and kidney by dietary Na depletion and dietary K depletion.

Authors: P Sangan; V M Rajendran; A S Mann; M Kashgarian; H J Binder
Journal: Am J Physiol Date: 1997-02

8. Epidemiology of community-acquired Clostridium difficile-associated diarrhea.

Authors: L R Hirschhorn; Y Trnka; A Onderdonk; M L Lee; R Platt
Journal: J Infect Dis Date: 1994-01 Impact factor: 5.226

9. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors: Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal: CMAJ Date: 2004-07-06 Impact factor: 8.262

Review 10. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease.

Authors: R C Spencer
Journal: J Antimicrob Chemother Date: 1998-05 Impact factor: 5.790

14 in total

1. First, the bad news...

Authors:
Journal: CMAJ Date: 2004-07-06 Impact factor: 8.262

2. Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice.

Authors: Usha Stiefel; Agam Rao; Michael J Pultz; Robin L P Jump; David C Aron; Curtis J Donskey
Journal: Antimicrob Agents Chemother Date: 2006-08-28 Impact factor: 5.191

10. Increasing incidence of clostridium difficile-associated diarrhea in African-American and Hispanic patients: association with the use of proton pump inhibitor therapy.

Authors: Abbasi J Akhtar; Magda Shaheen
Journal: J Natl Med Assoc Date: 2007-05 Impact factor: 1.798

Clostridium difficile infection in hospitals: risk factors and responses.

1. Autoradiographic demonstration of lansoprazole uptake sites in rat antrum and colon.

2. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

3. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

4. Identification of a vanadate-sensitive potassium-dependent proton pump from rabbit colon.

5. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.

6. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

7. Regulation of colonic H-K-ATPase in large intestine and kidney by dietary Na depletion and dietary K depletion.

8. Epidemiology of community-acquired Clostridium difficile-associated diarrhea.

9. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Review 10. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease.

1. First, the bad news...

2. Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice.

3. Treating C. difficile.

4. Strains and toxins of Clostridium.

5. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.

6. Key research issues in Clostridium difficile.

7. Does PPI therapy predispose to Clostridium difficile infection?

8. Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis.

9. Use of acid suppressive therapy in hospitalized non-critically ill patients.

10. Increasing incidence of clostridium difficile-associated diarrhea in African-American and Hispanic patients: association with the use of proton pump inhibitor therapy.